Vicore Pharma Holding AB VCRE
Annual
Quarterly
No annual revenue total was found in Vicore Pharma Holding AB's SEC filings.
Vicore Pharma Holding AB (VCRE) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VCRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Sweden
- Headquarters
- Stockholm
- SEC CIK
- 2124403
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 22, 2026 | Oct 31, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 21, 2026 | Aug 21, 2026 |
| 6-K | Current report (foreign issuer) | Jul 6, 2026 | Jul 6, 2026 |
All 12 Vicore Pharma Holding AB SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.